Article info
Clinical/translational cancer immunotherapy
Original research
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
- Correspondence to Dr Nick Powell; nicholas.powell{at}imperial.ac.uk
Citation
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
Publication history
- Accepted August 26, 2022
- First published September 16, 2022.
Online issue publication
March 12, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.